RA Capital Management - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 120 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.28 and the average weighting 1.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$1,100,000
-33.7%
9,900
-43.8%
0.11%
-32.7%
Q1 2015$1,660,000
-15.8%
17,6000.0%0.16%
-22.2%
Q4 2014$1,972,000
+82.6%
17,6000.0%0.21%
+65.6%
Q3 2014$1,080,000
-44.8%
17,600
-74.9%
0.13%
-37.3%
Q3 2013$1,957,00070,0000.20%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders